SHI [SINOPEC SHANGHAI PETROCHEMICAL CO] 6-K: 99.1 Announcement Regarding Estimated Growth in Profit for

[99.1 Announcement Regarding Estimated Growth in Profit for the First Six Months of 2016; and 99.2 Date of Meeting of the Board of Directors. SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED Wang Zhiqing President]

YZC [YANZHOU COAL MINING CO] 6-K: (Original Filing)

[Yanzhou Coal Mining Company Limited Date By YANZHOU COAL MINING COMPANY LIMITED (A joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 1171) UPDATE ON LITIGATIONS INVOLVING YANZHOU COAL MINING COMPANY LIMITED Yanzhou Coal Company Jinan Shizhong District Court Shandong Province Higher Court Jinan Branch of Minsheng Bank Yanzhou Coal Mining Company Limited]

IDI [IDI] 424B3: (Original Filing)

[PROSPECTUS IDI, Inc. 2,869,190 Shares of Common Stock Risk Factors The common stock offered in this prospectus involves a high degree of risk. See “ No underwriter or other person has been engaged to facilitate the sale of shares of our common stock in this offering. Each selling shareholder may be deemed an underwriter of the shares of our common]

By | 2016-07-09T02:52:27+00:00 July 8th, 2016|Categories: Chinese Stocks, IDI, SEC Original|Tags: , , , , , |0 Comments

YZC [YANZHOU COAL MINING CO] 6-K: Yanzhou Coal Mining Company Limited Date By YANZHOU

[Yanzhou Coal Mining Company Limited Date By YANZHOU COAL MINING COMPANY LIMITED (A joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 1171) UPDATE ON LITIGATIONS INVOLVING YANZHOU COAL MINING COMPANY LIMITED Yanzhou Coal Company Jinan Shizhong District Court Shandong Province Higher Court Jinan Branch of Minsheng Bank Yanzhou Coal Mining Company Limited]

IDI [IDI] 424B3: PROSPECTUS IDI, Inc. 2,869,190 Shares of Common Stock

[PROSPECTUS IDI, Inc. 2,869,190 Shares of Common Stock Risk Factors The common stock offered in this prospectus involves a high degree of risk. See “ No underwriter or other person has been engaged to facilitate the sale of shares of our common stock in this offering. Each selling shareholder may be deemed an underwriter of the shares of our common]

By | 2016-07-09T02:53:15+00:00 July 8th, 2016|Categories: Chinese Stocks, IDI, Webplus ver|Tags: , , , , , |0 Comments

OSN [Ossen Innovation] 6-K: (Original Filing)

[Ossen Innovation Enters into Non-Binding Letter of Intent with America-Asia Diabetes Research Upon completion of the Acquisition, the Company would indirectly own 90.27% of San MediTech. San MediTech's proprietary Dynamic Glucose Monitoring System ("DGMS") provides continuous, real-time monitoring of glucose level in diabetes patients, with two patents granted in China and several patents pending both in China and the U.S.] [FORM 6-K OSSEN INNOVATION CO., LTD. 518 SHANGCHENG ROAD, FLOOR 17, SHANGHAI, 200120, PEOPLE’S REPUBLIC OF CHINA Form 20-F x Form 40-F ¨ Yes ¨ No x OSSEN INNOVATION CO., LTD. Number Description 99.1 Press Release, dated July 8, 2016 6-K 1 v443938_6k.htm FORM 6-K]

IDI [IDI] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Event Reported): July 1, 2016 IDI, Inc. Delaware 333-158336 77-0688094 _____________________ _____________ ______________ of incorporation) Identification No.) 2650 North Military Trail, Suite 300, Boca Raton, Florida 33431 _________________________________ ___________ 561-757-4000 Not Applicable Top of the Form Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain]

By | 2016-07-09T02:54:35+00:00 July 8th, 2016|Categories: Chinese Stocks, IDI, SEC Original|Tags: , , , , , |0 Comments

OSN [Ossen Innovation] 6-K: Ossen Innovation Enters into Non-Binding Letter of Intent

[Ossen Innovation Enters into Non-Binding Letter of Intent with America-Asia Diabetes Research Upon completion of the Acquisition, the Company would indirectly own 90.27% of San MediTech. San MediTech's proprietary Dynamic Glucose Monitoring System ("DGMS") provides continuous, real-time monitoring of glucose level in diabetes patients, with two patents granted in China and several patents pending both in China and the U.S.] [FORM 6-K OSSEN INNOVATION CO., LTD. 518 SHANGCHENG ROAD, FLOOR 17, SHANGHAI, 200120, PEOPLE’S REPUBLIC OF CHINA Form 20-F x Form 40-F ¨ Yes ¨ No x OSSEN INNOVATION CO., LTD. Number Description 99.1 Press Release, dated July 8, 2016 6-K 1 v443938_6k.htm FORM 6-K]

IDI [IDI] 8-K: FORM 8-K CURRENT REPORT Date of Report (Date

[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Event Reported): July 1, 2016 IDI, Inc. Delaware 333-158336 77-0688094 _____________________ _____________ ______________ of incorporation) Identification No.) 2650 North Military Trail, Suite 300, Boca Raton, Florida 33431 _________________________________ ___________ 561-757-4000 Not Applicable Top of the Form Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain]

By | 2016-07-09T02:55:23+00:00 July 8th, 2016|Categories: Chinese Stocks, IDI, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] SC 13G: (Original Filing)

[1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Capital Research Global Investors ** 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 5 SOLE VOTING POWER 3,031,654 6 SHARED VOTING POWER NUMBER OF SHARES NONE BENEFICIALL Y OWNED]

Skip to toolbar